• Morgan Stanley Downgrades Biogen (LSE:0R1B)

    ソース: NASDAQ Stocks / 01 11 2024 02:56:28   America/Chicago

    Fintel reports that on October 31, 2024, Morgan Stanley downgraded their outlook for Biogen (LSE:0R1B) from Overweight to Equal-Weight. https://www.nasdaq.com/articles/morgan-stanley-downgrades-biogen-lse-0r1b
シェアする